SAN DIEGO, Nov. 5, 2010 (GLOBE NEWSWIRE) -- The MyGlucoHealth diabetes management system recently received regulatory approval in India. The MyGlucoHealth system includes the MyGlucoHealth Wireless glucometer, test strips, mobile phone application and online portals. Regulatory approval from Central Drugs Standard Control Organisation, (Food and Drug Administration Bhavan, New Delhi) ensures that MyGlucoHealth strips meets Indian standards of quality, safety, and efficacy. The MyGlucoHealth license number is NCD 145/10.
"India is often referred to as the 'diabetes capital of the world,' with the highest number of diabetic patients of any country," said Richard Strobridge, CEO of Entra Health Systems, maker of MyGlucoHealth. "MyGlucoHealth offers a comprehensive solution to help over 40 million diabetics in India better manage their condition using a mobile phone and online services. Since most Indians have mobile phones, but few have computers, we have developed a unique solution, in conjunction with major clinical care groups in India, to enable patients to upload test results to the MyGlucoHealth online portal using SMS messaging technology. This gives users access to the alerts and messaging features of MyGlucoHealth without the need for costly data plans."
MyGlucoHealth provides a quick and convenient way for persons with diabetes to measure and self-manage blood glucose levels. Using automated tools, MyGlucoHealth sends reminders to encourage patients to test more frequently, as well as to notify family, caregivers and clinicians when testing results reach critical levels. MyGlucoHealth gives patients more direct control over their care and provides clear lines of communication with clinicians and caregivers.
The MyGlucoHealth Wireless blood glucose meter and other consumables will be available throughout India in the coming months. For information on product availability or distribution opportunities within India, contact Shailesh Gadre, director of GCV Life Pvt. Ltd. in Mumbai, email@example.com
MyGlucoHealth Wireless from Entra Health Systems is the first and only FDA cleared and CE certified Bluetooth®-enabled glucometer of its kind in the world. MyGlucoHealth works in combination with a real-time online data collection network to securely upload and manage blood glucose readings using a mobile phone or PC eliminating the need to maintain personal logbooks.
The meter, along with the MyGlucoHealth Network, form an integrated telehealth platform supporting patients and healthcare professionals in the control and treatment of diabetes. For more information visit: www.myglucohealth.net
The MyGlucoHealth Wireless logo is available at http://www.globenewswire.com/newsroom/prs/?pkgid=6117
About GCV Life
Emerging markets undoubtedly represent an attractive opportunity for many a healthcare companies owing to their vast untapped potential; however, the clinical needs in these markets and the business models needed to address them may be substantially different from those in vogue in the developed markets. GCV Life is an investment banking firm focused on bringing about 'healthcare commercialization' in emerging markets. GCV Life picks-up new areas of disease management / technological innovations and facilitate access to innovators into emerging markets.
GCV Life's mission is to provide knowledge-driven access to business synergies. www.gcvlife.in
CONTACT: Entra Health Systems Media Contacts Bruce Ahern, Chief Marketing Officer 877-458-2646 x708 +1 678 492 8359 firstname.lastname@example.org GCV Life Pvt Ltd Shailesh Gadre, Managing Director + 91 22 42547001 email@example.com